InVivo Therapeutics Holdings Corp Shares Close the Day 11.0% Lower - Daily Wrap
The company saw its shares close the day 11.0% lower than yesterday, with trading volume lower than its 30 day average.
Dec 29, 2021 by Kwhen Finance Editors
InVivo Therapeutics Holdings Corp (NVIV) shares closed today 11.0% lower than it did at the end of yesterday. The stock is currently down 34.0% year-to-date, down 20.1% over the past 12 months, and down 99.6% over the past five years. Today, the Dow Jones Industrial Average rose 0.3%, and the S&P 500 fell 0.1%.
Trading Activity
- Shares traded as high as $0.58 and as low as $0.52 this week.
- Shares closed 76.2% below its 52-week high and 1.4% below its 52-week low.
- Trading volume this week was 5.9% higher than the 10-day average and 50.7% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| InVivo Therapeutics Holdings Corp | -11.0 | -34.0 | -20.1 | -73.4 | 10.3 |
| Dow Jones Industrial Average | 0.3 | 20.7 | 22.2 | -0.3 | 23.6 |
| S&P 500 Index | -0.1 | 29.4 | 31.1 | 0.1 | 32.7 |
| Health Care | -0.3 | 23.4 | 25.0 | 0.2 | 27.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 174.5%
- The company's stock price performance over the past 12 months lags the peer average by 62.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| InVivo Therapeutics Holdings Corp | NVIV | 0 | -34.0 | -20.1 | -73.4 | 10.3 |
| Peer Avg | N/A | 18.6 | -12.4 | -12.4 | -35.8 | 18.7 |
| Boston Scientific Corp. | BSX | 55.8 | 19.9 | 24.7 | -6.9 | 24.7 |
| Cytosorbents Corp | CTSO | 0 | -45.0 | -47.3 | -62.8 | 4.1 |
| Daxor Corporation | DXR | 0 | -12.0 | -14.5 | -37.9 | 27.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: